![nancy-lin-and-margaret-campbell653x447.jpg](https://dfci.widen.net/content/2c4c4491-09c4-447b-af3f-e4ed5c960150/web/nancy-lin-and-margaret-campbell653x447.jpg?w=480&itok=OTGDvCCq)
We believe outstanding clinical care for patients with breast cancer is directly linked to an active program of breast cancer clinical trials. Our physician-scientists take the questions that arise in their clinical practices, answer them through clinical trials, and take this new knowledge back to the clinic where it can immediately benefit patients.
Breast cancer investigators are tackling cancer on multiple fronts, including immunotherapy and targeted treatments for the three subtypes: hormone receptor positive, HER2-positive, and triple-negative. This work includes primary tumors and metastatic cancer.
Clinical Trials
We offer our breast cancer patients access to more than 40 clinical trials at a time — many of which are changing the standard of care worldwide and are not available elsewhere. Our clinical trials focus on the types and phases of your disease so therapy can be targeted to your type of breast cancer.